Ignite Creation Date:
2024-05-06 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06172751
Status:
COMPLETED
Last Update Posted:
2024-05-29
First Post:
2023-12-07
Brief Title:
TrinetX Study of Hypereosinophilic Syndrome HES Without an Identifiable Non-haematological Secondary Cause
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-15
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-26
Completion Date Type:
ACTUAL
First Submit Date:
2023-12-07
First Submit QC Date:
December 7 2023
Study First Post Date:
2023-12-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-28
Last Update Post Date:
2024-05-29
Last Update Post Date Type:
ACTUAL